Skip to main content

Table 1 Anthropometric and clinical characteristics of control subjects and patients with type 2 diabetes at baseline

From: Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype

 

Control group (N = 54)

Type 2 diabetes (N = 122)

Age (years)

56 ± 14

59 ± 11

Diabetes duration (years)

-

10.61 ± 10.26

Chronic complications:

-

 

   ● Retinopathy (%)

 

29.7

   ● Nephropathy (%)a

 

32.4

   ● Coronary Heart Disease (%)

 

9.9

Antihypertensive medication (%)

-

67.9

Cholesterol lowering medication (%)

-

33.6

Weight (kg)

69.3 ± 11.4

82.1 ± 18.8*

Waist (cm)

92 ± 11

105 ± 14*

Body mass index (Kg/m2)

25.9 ± 3.5

30.2 ± 5.6*

  1. Data are expressed mean ± SD.
  2. aNephropathy defined as impaired renal function (eGFR < 60 ml/minut) or 2 or more urinary determinations of microalbuminuria ≥ 20 mg/l or ≥ 30 mg/g of creatinine.
  3. *Statistically significant (p <0.05).
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840